1. Home
  2. ZWS vs PRAX Comparison

ZWS vs PRAX Comparison

Compare ZWS & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zurn Elkay Water Solutions Corporation

ZWS

Zurn Elkay Water Solutions Corporation

HOLD

Current Price

$50.43

Market Cap

7.9B

Sector

Industrials

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$337.29

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZWS
PRAX
Founded
1900
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
9.0B
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
ZWS
PRAX
Price
$50.43
$337.29
Analyst Decision
Buy
Strong Buy
Analyst Count
6
15
Target Price
$53.67
$572.13
AVG Volume (30 Days)
1.1M
326.2K
Earning Date
04-21-2026
05-08-2026
Dividend Yield
0.86%
N/A
EPS Growth
25.00
N/A
EPS
0.35
N/A
Revenue
$1,530,500,000.00
N/A
Revenue This Year
$6.90
N/A
Revenue Next Year
$5.13
$7,758.26
P/E Ratio
$146.34
N/A
Revenue Growth
19.40
N/A
52 Week Low
$33.95
$34.89
52 Week High
$53.76
$354.87

Technical Indicators

Market Signals
Indicator
ZWS
PRAX
Relative Strength Index (RSI) 54.55 55.91
Support Level $44.89 $282.49
Resistance Level $51.18 $353.83
Average True Range (ATR) 1.60 18.75
MACD 0.09 -0.96
Stochastic Oscillator 54.39 69.67

Price Performance

Historical Comparison
ZWS
PRAX

About ZWS Zurn Elkay Water Solutions Corporation

Zurn Elkay Water Solutions Corp is a growth-oriented, pure-play water management business that designs, procures, manufactures, and markets the broadest sustainable product portfolio of specification-driven water management solutions to improve health, hydration, human safety and the environment. Its product portfolio includes professional grade water safety and control products, flow systems products, hygienic and environmental products, and filtered drinking water products for public and private spaces that deliver superior value to building owners, positively impact the environment and human hygiene and reduce product installation time.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: